Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
The Journal of Pharmacy and Pharmacology|January 30, 2013
Effect of protamine on the accumulation of gentamicin in opossum kidney epithelial cellsJunya Nagai, Takuji Komeda, Ryoko Yumoto, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 16, 2020
Safety and effectiveness of baloxavir marboxil for the treatment of influenza in Japanese clinical practice: A postmarketing surveillance of more than 3000 patientsMasami Nakazawa, Kanae Hara, Takuji Komeda, et al.Therapeutic Innovation & Regulatory Science|April 12, 2026
Does the Epoch-Making Guideline Need Instructions for Use?: Analyzing Adverse Events Collected through Selective Safety Data Collection Under ICH E19 Guideline with Addressing Implementation ConsiderationsHayato Niiyama, Takuji Komeda, Ayako Kitami, et al.Therapeutic Innovation & Regulatory Science|March 31, 2022
Estimation of a Suitable Number of Patients for Selective Safety Data Collection (ICH E19 Draft Guideline): When is the Safety Profile of a Drug Well Characterized?Hiroyuki Saeki, Takuji Komeda, Risa Tanaka, et al.Biological & Pharmaceutical Bulletin|December 3, 2013
Characterization of protamine uptake by opossum kidney epithelial cellsJunya Nagai, Takuji Komeda, Yuki Katagiri, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 8, 2016
Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factorsTakuji Komeda, Shingo Ishii, Yumiko Itoh, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 13, 2024
Symptoms of post COVID-19 condition and diseases/conditions diagnosed after COVID-19 in Japanese patients: A real-world study using a claims databaseSatoshi Kutsuna, Ryotaro Tajima, Genta Ito, et al.Therapeutic Innovation & Regulatory Science|May 13, 2022
How Many Clinical Trials Exist that Have Adopted Selective Safety Data Collection? NEJM Literature Search Results: The Possibility of Harmonizing the ICH E19 GuidelineYuki Yamatani, Hiroyuki Saeki, Risa Tanaka, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 20, 2014
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigationTakuji Komeda, Shingo Ishii, Yumiko Itoh, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2014
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigationTakuji Komeda, Shingo Ishii, Yumiko Itoh, et al.Pageof 2